Techne buys antibody-maker for $20M

Techne says its R&D Systems division has acquired Fortron Bio Science and BiosPacific for about $20 million. Fortron makes monoclonal and polyclonal antibodies and BiosPacific is its primary distribution arm.

- read this report from the AP for more

Suggested Articles

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.

GSK poaches Merck KGaA's Martinez-Davis to helm pharma stateside; Bulto named Novartis U.S. pharma head; Allergan's Saunders set for huge parachute.